Natera Announces MedicareCoverage of Signatera™ for Surveillance in Lung Cancer
FES-PET Resources
- Cerianna™ (fluoroestradiol F18) Resources
- Cerianna™ (fluoroestradiol F18) Support
- FES-PET: Promising for Staging Invasive Lobular Carcinoma
- FES-PET: Promising for Staging for ER-Positive Breast Cancer
- Educational Handbook: Invasive Lobular Cancer: Current Evidence and Clinical Impact
- FES PET/CT Included in NCCN Practice Guidelines for Breast Cancer for Systemic Staging of ER+ Recurrent/Stage IV (M1) Disease